<DOC>
	<DOCNO>NCT00791739</DOCNO>
	<brief_summary>The study double purpose : first phase intend assess effectiveness tolerability trazodone , antidepressant sedative sleep-promoting property , treatment fibromyalgia ; second phase intend evaluate addition pregabalin patient show partial response trazodone additionally improve fibromyalgia symptomatology .</brief_summary>
	<brief_title>Trazodone Its Augmentation With Pregabalin Treatment Fibromyalgia</brief_title>
	<detailed_description />
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<mesh_term>Trazodone</mesh_term>
	<criteria>patient diagnose fibromyalgia accord American College Rheumatology criterion write , informed consent able understand comply requirement study pregnancy breastfeed unwillingness discontinue prescribe medication enter study patient previously receive trazodone without improvement tolerate drug patient previously receive pregabalin without improvement tolerate drug ( phase II study )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>fibromyalgia</keyword>
	<keyword>trazodone</keyword>
	<keyword>pregabalin</keyword>
	<keyword>Fibromyalgia Impact Questionnaire ( FIQ )</keyword>
	<keyword>Pittsburgh Sleep Quality Inventory ( PSQI )</keyword>
	<keyword>Brief Pain Inventory ( BPI )</keyword>
</DOC>